Category: HPV

JAMA Pediatrics shows HPV vaccine effective

Posted on by

In this cross-sectional study among 2335 adolescent girls and young adult women, relative differences in positivity for HPV types decreased significantly for 2-valent, 4-valent, and 9-valent vaccine–type HPV among vaccinated participants and 2-valent and 4-valent vaccine–type HPV among unvaccinated participants. This study found that population-level effectiveness and herd protection were robust in sexually experienced adolescent girls and young women at relatively high risk for HPV. Read the study

HPV Vaccine Prevents Cancer.

Posted on by

From Paul Offit’s “Beyond the Noise:” Human papillomavirus (HPV) causes cancer. Every year, HPV causes about 20,000 cancers in women and 14,000 in men. For women, HPV is the only known cause of cervical cancer, accounting for about 11,000 cases and 4,000 deaths every year. For men, HPV is a common cause of head, neck, anal, and genital cancers. The first vaccine to prevent HPV (Gardasil) was licensed in 2006. With the licensure of an HPV vaccine that protected against additional strains in 2014, the incidence of cervical cancer has dropped 62 percent over the past decade. Perhaps no vaccine Read More …

Call for Abstracts – HPV Conference

Posted on by

Call for abstracts for the inaugural National HPV conference (April 15-17, 2025 in Indianapolis, IN). This conference is aimed towards those working in HPV prevention, screening, and control (more info on the conference found here: https://nhpvc.org/). Timelines for abstract submissions and conference registration can be found below (2025 National HPV Conference_Call for Abstracts). Call for abstracts submissions open: June 15, 2024 Deadline for abstract submission: September 15, 2024, 8:00 pm EST Deadline for review of abstracts: October 15, 2024, 8:00 pm EST Program decision: November 15, 2024 Conference registration & reservations: November 15, 2024

Posted in HPV

National Vaccination Coverage Among Adolescents, 2021

Posted on by

The CDC has just released the National Vaccination Coverage Among Adolescents Aged 13-17 Years, 2021.  “Among adolescents aged 13–17 years in 2021, HPV vaccination coverage (≥1 dose and HPV vaccine up to date) increased. Coverage with ≥1-dose Tdap and ≥1-dose MenACWY remained high. Among age-eligible adolescents, MenACWY booster dose coverage increased. Analyses of the potential COVID-19 pandemic effect among adolescents born in 2008 show a concerning decrease in ≥1 MenACWY and ≥1 Tdap dose coverage.”  Read more

As HPV Vaccination Rose, Disease Prevalence Fell

Posted on by

In the first 12 years of an HPV vaccination program in the U.S., prevalence of the most common sexually transmitted infection fell among vaccinated and unvaccinated females as well as males, new research shows, hinting at herd immunity. Read more